| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.06 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.3 | 0.07 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |